These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8453635

  • 1. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S, Börresen AL, Eyfjörd JE.
    Cancer Res; 1993 Apr 01; 53(7):1637-41. PubMed ID: 8453635
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 3. p53 mutations occur in aggressive breast cancer.
    Mazars R, Spinardi L, BenCheikh M, Simony-Lafontaine J, Jeanteur P, Theillet C.
    Cancer Res; 1992 Jul 15; 52(14):3918-23. PubMed ID: 1617667
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. p53 mutations and prognosis in bladder tumors.
    Uchida T, Wada C, Ishida H, Wang C, Egawa S, Yokoyama E, Kameya T, Koshiba K.
    J Urol; 1995 Apr 15; 153(4):1097-104. PubMed ID: 7869472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands.
    Van Den Broek MH, Renault B, Fodde R, Verspaget H, Griffioen G, Khan PM.
    Anticancer Res; 1993 Apr 15; 13(3):587-92. PubMed ID: 8317886
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Base transitions are the most frequent genetic changes at P53 in gastric cancer.
    Renault B, van den Broek M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN.
    Cancer Res; 1993 Jun 01; 53(11):2614-7. PubMed ID: 8495424
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS.
    Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J, Thompson AM, Cranston G, Evans HJ.
    Oncogene; 1990 Oct 15; 5(10):1573-9. PubMed ID: 2250913
    [Abstract] [Full Text] [Related]

  • 18. p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.
    Saitoh S, Cunningham J, De Vries EM, McGovern RM, Schroeder JJ, Hartmann A, Blaszyk H, Wold LE, Schaid D, Sommer SS.
    Oncogene; 1994 Oct 15; 9(10):2869-75. PubMed ID: 8084591
    [Abstract] [Full Text] [Related]

  • 19. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.